Cancer

Health Anil Oza

With rising cancer rates in younger adults, experts emphasize better tests

Morning Rounds Brittany Trang

Scientists weigh in on RFK Jr. as HHS secretary

Health Jason Mast

STAT Plus: ‘Worst imaginable’ brain tumor yields, in some young people, to CAR-T therapy

Pharma Matthew Herper and Adam Feuerstein

STAT Plus: Merck licenses Chinese cancer drug, searching for next Keytruda blockbuster

Health tech Mario Aguilar

STAT Plus: How Pfizer used wearables to tap into the promise of an experimental drug

Health tech Mohana Ravindranath

STAT Plus: OpenAI isn’t built for health care. So why is its tech already in hospitals, pharma, and cancer care?

Pharma Andrew Joseph

STAT Plus: AstraZeneca, Daiichi Sankyo change strategy on closely watched cancer drug

First Opinion William Chun-Ying Chen and Louis Potters

Tattoo-less radiation treatment is the future of cancer care

Morning Rounds Theresa Gaffney

Trump elected to the presidency again, as Republicans take the Senate

Biotech Adam Feuerstein

STAT Plus: Early data from Arcellx, Gilead suggest CAR-T for multiple myeloma could offer safety benefit

Business Jonathan Saltzman — Boston Globe

STAT Plus: Amid divorce from Dana-Farber, Mass General Brigham touts its own cancer institute

Exclusive Bob Herman

STAT Plus: Warren wants close FTC scrutiny of drug distributors buying cancer medical groups

Who to Know Angus Chen

STAT Plus: Dreams of cancer vaccines are becoming more real. Here are 9 scientists making it happen 

Pharma Andrew Joseph

STAT Plus: Novartis raises profit guidance, pushes off myelofibrosis drug submission

Biotech Andrew Joseph

STAT Plus: Novartis, Seagen veteran David Epstein is back, leading a new cancer startup

Pharmalot Ed Silverman

STAT Plus: A drug may cause problems with chemotherapies in cancer patients with obesity. Many doctors are in the dark

Adam's Take Adam Feuerstein

STAT Plus: Gilead needs a win with Arcellx CAR-T data. Here’s how to know if it scores

Adam's Take Adam Feuerstein

STAT Plus: Elon Musk bungles his criticism of U.S. drug regulators

Health STAT Staff

How a tragic diagnosis sent a journalist on a scientific odyssey

Health Anil Oza

Their research may be transformative. They worry patients won’t be able to access it

Health Angus Chen

130,000 U.S. cancer cases went undiagnosed in Covid pandemic, study finds

Biotech Allison DeAngelis

STAT Plus: Chasing CAR-T, biotech finds its next gold rush in autoimmune disease

Biotech Jason Mast

STAT Plus: 7 children developed blood cancer after Bluebird Bio gene therapy for rare neurological disease

Pharmalot Ed Silverman

STAT Plus: GSK to pay up to $2.2 billion to settle most Zantac lawsuits over claims the heartburn pill causes cancer

Biotech Jonathan Wosen

STAT Plus: Exact Sciences wins FDA approval for improved stool-based colon cancer test

In the Lab Angus Chen

STAT Plus: Q&A: AI is coming for lots of jobs. What about that of the cancer researcher?

Morning Rounds Theresa Gaffney

Morning Rounds: Women with sickle cell are sterilized postpartum more than others

Health Anil Oza

Why do Black Americans get more aggressive cancers?

Pharma Andrew Joseph

STAT Plus: Roche seeks to project confidence on its obesity drugs — and sees room to make its mark